Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Income Taxes (Details) - Schedule of components of company's deferred tax assets and liabilities

v3.25.0.1
Income Taxes (Details) - Schedule of components of company's deferred tax assets and liabilities - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Deferred tax assets    
Tax losses carry forwards $ 755,431,000 $ 682,095,000
Inventory related 2,500,000 2,241,000
Intangible assets 11,465,000 16,990,000
Provision for employee related obligations 2,380,000 703,000
Stock-based compensation 9,838,000 8,803,000
Deferred revenue 4,524,000 3,742,000
Property, plant and equipment 254,000 0
Allowance for credit losses 173,000 119,000
Research and development credit carry forwards 21,577,000 20,368,000
Research and development capitalization (including Section 174) 22,952,000 19,384,000
Deferred Tax Assets, Equity Method Investments 9,240,000 1,406,000
Deferred tax assets (under "Other non-current assets") 6,491,000 5,320,000
Gross deferred tax assets 846,825,000 761,171,000
Valuation allowance (826,870,000) (737,560,000)
Total deferred tax assets 19,955,000 23,611,000
Deferred tax liabilities    
Intangibles assets (7,423,000) (8,803,000)
Property, plant and equipment (12,077,000) (14,228,000)
Total deferred tax liabilities (19,500,000) (23,031,000)
Net deferred tax assets (liabilities) $ 455,000 $ 580,000